South Korea to start talks on COVID-19 drug remdesivir purchases
South Korea said it will begin talks with Gilead Sciences to purchase stocks of remdesivir, one of the first drugs shown to be effective against COVID-19, after the company agreed to allocate nearly all of its supply to the U.S. over the next three months.
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters on Twitter: https://twitter.com/Reuters Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
South Korea said it will begin talks with Gilead Sciences to purchase stocks of remdesivir, one of the first drugs shown to be effective against COVID-19, after the company agreed to allocate nearly all of its supply to the U.S. over the next three months.
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters on Twitter: https://twitter.com/Reuters Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en